Amneal制药公司2024年第四季度调整后每股收益$0.12,低于预期$0.15,销售额$7.3052亿,超出预期$7.0755亿

财报速递2025-02-28
Amneal制药公司(NASDAQ:AMRX)报告季度每股收益为$0.12,比分析师一致预期的$0.15低20%。这比去年同期每股收益的$0.14减少了14.29%。公司报告季度销售额为$7.3052亿,比分析师一致预期的$7.0755亿高3.25%。这比去年同期的销售额$6.1698亿增长了18.40%。

以上内容来自Benzinga Earnings专栏,原文如下:

Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.15 by 20 percent. This is a 14.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $730.52 million which beat the analyst consensus estimate of $707.55 million by 3.25 percent. This is a 18.40 percent increase over sales of $616.98 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法